Thomas Joseph Russo - 10 Feb 2015 Form 4 Insider Report for Icosavax, Inc.

Role
Chief Financial Officer
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact for Thomas Joseph Russo
Issuer symbol
N/A
Transactions as of
10 Feb 2015
Net transactions value
$0
Form type
4
Filing time
14 Feb 2022, 18:08:13 UTC
Next filing
28 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Award $0 +17,714 +52% $0.000000 51,880 10 Feb 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Award $0 +74,500 $0.000000 74,500 10 Feb 2022 Common Stock 74,500 $17.55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") which will vest as to 25% of the total number of RSUs granted on each of the first four anniversaries of February 10, 2022, subject to the reporting persons continued service through the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer and the RSUs have no expiration date.
F2 Includes 1,666 shares acquired under the Issuer's employee stock purchase plan on November 30, 2021.
F3 25% of the shares subject to the option will vest on February 10, 2023, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the reporting person's continued service through the applicable vesting date.

Remarks:

Exhibit 24 Power of Attorney